Oie S, Sawa A, Kamiya A, Mizuno H
Department of Pharmacy Clinical Laboratory, Yamaguchi University Hospital, 1144 Kogushi, Ube 755, Japan.
J Antimicrob Chemother. 1999 Nov;44(5):689-91. doi: 10.1093/jac/44.5.689.
We evaluated the in-vitro effects of various combinations of five types of widely used antipseudomonal antibiotics (piperacillin, meropenem, ceftazidime, aztreonam and amikacin) against six Pseudomonas aeruginosa strains that were resistant to each of these antibiotics. Among two-drug combinations, the combinations of two beta-lactam antibiotics inhibited growth of one to three P. aeruginosa strains, while those of one beta-lactam antibiotic and amikacin inhibited growth of two to four strains. Among three-drug combinations, the combinations of three beta-lactam antibiotics inhibited growth of four to five strains, and those of two beta-lactam antibiotics and amikacin inhibited growth of five strains. These results suggest the potential usefulness of a combination of two beta-lactam antibiotics and amikacin or that of three beta-lactam antibiotics in treating multi-drug resistant P. aeruginosa infections.
我们评估了五种广泛使用的抗假单胞菌抗生素(哌拉西林、美罗培南、头孢他啶、氨曲南和阿米卡星)的各种组合对六种对这些抗生素均耐药的铜绿假单胞菌菌株的体外作用。在两药组合中,两种β-内酰胺抗生素的组合抑制了1至3株铜绿假单胞菌的生长,而一种β-内酰胺抗生素与阿米卡星的组合抑制了2至4株菌株的生长。在三药组合中,三种β-内酰胺抗生素的组合抑制了4至5株菌株的生长,而两种β-内酰胺抗生素与阿米卡星的组合抑制了5株菌株的生长。这些结果表明,两种β-内酰胺抗生素与阿米卡星的组合或三种β-内酰胺抗生素的组合在治疗多重耐药铜绿假单胞菌感染方面具有潜在的实用性。